Healthcare | January 25, 2023
75% of asthma patients have worse symptoms during cold or flu
Asthma patients are more likely to have an asthma attack during winter
Asthma patients are more likely to have an asthma attack during winter
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers
Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Subscribe To Our Newsletter & Stay Updated
